Tabriz University of Medical Sciences About    Newsletter    Contact Us    Create Account    Log in  
Journal of Analytical Research in Clinical Medicine
   eISSN: 2345-4970  
Services
Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks
Mendeley

Cite by
Google Scholar



Article History
Submitted: 01 Feb 2018
Accepted: 04 Feb 2018
First published online: 04 Feb 2018

Article Access Statistics
Abstract Page Views: 148
PDF Downloads: 325
Full Text Views: 0

J Anal Res Clin Med. 2018;6(1):28-33 doi: 10.15171/jarcm.2018.005

Investigation of the role of procalcitonin in early diagnosisof infective endocarditis

Original Article

Zhinous Bayat –Makoo 1, Rezvaniye Salehi 2, Alireza Motallemi 3, Mohammad Naghavi – Behzad 4, Hadiseh Kavandi 5 *

1 Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 Cardiovascular Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
3 Department of Infectious Diseases, Tabriz University of Medical Sciences, Tabriz, Iran
4 Student's Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
5 Medical Philosophy and History Research Center, Tabriz University of Medical Sciences, Tabriz, Iran



Abstract
Introduction: Infective endocarditis (IE) is a life-threatening condition with incidence of 30-100 per million individuals. It is introduced as the 4th disease among life-threatening diseases. The present study was carried out with the aim to compare serum level of procalcitonin (PCT) at the time of diagnosis and at the end of treatment period among patients with IE. Methods: In this descriptive cross-sectional study which was performed in department of infectious diseases and cardiology on the patients with IE, PCT level was measured at the time of diagnosis and at the end of treatment period. Results: In this study, 50 patients with IE were evaluated. All of them were febrile. Positive blood culture (PBC) was found among 36% of patients. Involvement of tricuspid valve was detected among 34% of patients. Mean level of PCT was 3.50 ± 13.78 and 14.12 ± 0.00 mg/dl at the time of diagnosis and at the end of treatment period, respectively. Hence, the PCT level at the end of treatment period was significantly lower than that at the time of diagnosis. Conclusion: PCT along with other laboratory and clinical biomarkers can be useful in primary diagnosis and evaluation of response to treatment among patients with IE.





Comments
First name  
Last name  
Email address  
Comments  
Security code



This Article
PDF

Google Scholar
Articles by Bayat –Makoo Z
Articles by Salehi R
Articles by Motallemi A
Articles by Naghavi – Behzad M
Articles by Kavandi H

PubMed
Articles by Bayat –Makoo Z
Articles by Salehi R
Articles by Motallemi A
Articles by Naghavi – Behzad M
Articles by Kavandi H



Share this article!
© 2017 Tabriz University of Medical Sciences; unless otherwise stated.

Press Manuscript Online. Powered by MAADRAYAN